Avisa Diagnostics Inc.
FOGCF
$0.00
$0.000.00%
OTC PK
| 06/30/2021 | |||||
|---|---|---|---|---|---|
| Revenue | -- | ||||
| Total Other Revenue | -- | ||||
| Total Revenue | -- | ||||
| Cost of Revenue | -- | ||||
| Gross Profit | -- | ||||
| SG&A Expenses | 172.12% | ||||
| Depreciation & Amortization | 93.94% | ||||
| Other Operating Expenses | -- | ||||
| Total Operating Expenses | 179.13% | ||||
| Operating Income | -179.13% | ||||
| Income Before Tax | -481.78% | ||||
| Income Tax Expenses | -- | ||||
| Earnings from Continuing Operations | -481.78% | ||||
| Earnings from Discontinued Operations | -- | ||||
| Extraordinary Item & Accounting Change | -- | ||||
| Minority Interest in Earnings | -- | ||||
| Net Income | -481.78% | ||||
| EBIT | -179.13% | ||||
| EBITDA | -181.91% | ||||
| EPS Basic | -126.69% | ||||
| Normalized Basic EPS | -126.13% | ||||
| EPS Diluted | -126.69% | ||||
| Normalized Diluted EPS | -126.13% | ||||
| Average Basic Shares Outstanding | 1,330.05% | ||||
| Average Diluted Shares Outstanding | 1,330.05% | ||||
| Dividend Per Share | -- | ||||
| Payout Ratio | -- | ||||